• 1
    Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States: Numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop Relat Res 1990;252:163166.
  • 2
    Sakuma M, Endo N, Oinuma T et al. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 2006;17:16081614.
  • 3
    Bischoff-Ferrari HA, Can U, Staehelin HB et al. Severe vitamin D deficiency in Swiss hip fracture patients. Bone 2008;42:597602.
  • 4
    Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266281.
  • 5
    Rosen CJ, Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 2003;348:15031504.
  • 6
    Harwood RH, Sahota O, Gaynor K et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing 2004;33:4551.
  • 7
    Lyles KW, Colon-Emeric CS, Magaziner JS et al. Zoledronic acid and clinical fractures and mortality after hip fracture. HORIZON recurrent fracture trial. N Engl J Med 2007;357:1799809.